The team of Prof. Kewu Zeng and Prof. Pengfei Tu has revealed a new molecular target of homoharringtonine for anti-leukemia

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (12): 1145-1145.

• News • Previous Articles Next Articles

The team of Prof. Kewu Zeng and Prof. Pengfei Tu has revealed a new molecular target of homoharringtonine for anti-leukemia

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2025-11-20 Revised:2025-11-20 Accepted:2025-11-20 Online:2025-12-31 Published:2025-12-31

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The team of Prof. Kewu Zeng and Prof. Pengfei Tu has revealed a new molecular target of homoharringtonine for anti-leukemia[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(12): 1145-1145.

The team of Prof. Kewu Zeng and Prof. Pengfei Tu has revealed a new molecular target of homoharringtonine for anti-leukemia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments